Short Lecture “Isoquinoline alkaloids and their derivatives as a new class of antimycobacterial drugs”
Lucie Cahlíková, Abdullah Al Mamun, Ondřej Janďourek, Kateřina Sobolová, Jana Křoustková, Jan Korábečný, Rozálie Peřinová, Kateřina Breiterová
Planta Medica · 2022-12
Abstract
Tuberculosis (TB) is a widespread infectious disease caused by Mycobacterium tuberculosis (Mtb). According to the Global Tuberculosis Report 2021, issued by the World Health Organization (WHO), the latent form of Mtb has infected about a quarter of the worldʼs population, but only a small part (5 – 10%) will develop this bacterial disease [1]. The increasing incidence of multidrug-resistant (MDR), and extensively drug-resistant (XDR) strains has created a need for new antiTB agents with new chemical scaffolds to combat the disease. Thus, the key question is: how to search for new antiTB and where to look for them? One of the possibilities is to search among natural products.
MeSH terms
- Antimycobacterial
- Tuberculosis
- Mycobacterium tuberculosis
- Isoquinoline
- Disease
- Infectious disease (medical specialty)
- Medicine
- Drug
- Population
- Multiple drug resistance
- Drug resistance
- Biology